Invest in early detection with SpotitEarly
Every Moment Counts!
Invest in early
Detection
With SpotitEarly
Every Moment Counts!
This is your opportunity to support a life-changing
innovation - and grow with it.
SpotitEarly aims to transform how cancer is detected developing a simple, non-invasive breath test powered
by AI and the extraordinary sense of smell in trained dogs. Our goal: detect cancer early, when it’s most treatable, and help save lives.
Now, there’s a limited-time opportunity for you to join
that mission. Backed by leading VCs and private investors, SpotitEarly is opening the door to new investors.
By submitting your phone number, you consent to receive SMS support messages from SpotItEarly. Message frequency may vary. Message & data rates may apply. Text HELP for assistance. You may reply STOP to unsubscribe at any time.
Increasing
Adoption of
Cancer Screening
"These clinical findings are not just a scientific milestone - they’re a glimpse into the future of diagnostics. The ability to detect multiple cancers with this level of accuracy is unprecedented and has the potential to improve cancer detection and care globally."
Dr. Len Lichtenfeld, SpotitEarly CMO & Former Deputy Chief Medical Officer of the American Cancer Society
Accessible
Easy &
Accurate
We are developing a test to collect a simple breath sample collected at home in minutes.
Non-invasive
Affordable and accessible
No side effects, no preparation needed
No clinic visits required
Online prescription, no
appointments or lost workdays
Accessible
Easy &
Accurate
We are developing a test to collect a simple breath sample collected at home in minutes.
• Non-invasive
• Affordable and accessible
• No side effects, no
preparation needed
• No clinic visits required
• Online prescription, no
appointments or lost workdays
Early Stage Cancer
Detection Rates
Creating a Future Where Everyone's in the Know
DISCLAIMER
The securities referred to in this website may be sold only to accredited investors, which for natural persons, are investors who meet certain minimum annual income or net worth thresholds. These securities are being offered in reliance on an exemption from the registration requirements of the Securities Act and are not required to comply with specific disclosure requirements that apply to registration under the Securities Act. The Securities and Exchange Commission has not passed on the merits of or given its approval to the securities, the terms of the offering, or the accuracy or completeness of any offering materials. The securities are subject to legal restrictions on transfer and resale and investors should not assume that they will be able to resell their securities. Investing in securities involves risk, and investors should be able to bear the loss of their investment.
SAFE HARBOR STATEMENT
Matters discussed in this website contain forward-looking statements. When used in this update, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with our history of losses and our need to raise additional financing, the acceptance of our products and technology in the marketplace, our ability to demonstrate the commercial viability of our products and technology and our need to increase the size of our organization. Further information on the Company's risk factors is contained in the Company's Private Offering Memorandum. The Company undertakes no obligation to revise or update publicly any forward-looking statements for any reason except as may be required under applicable law.
Copyright © SpotItEarly 2025. All Rights Reserved.